Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Reflex Mediated Core Stability Exercise on Sensory Processing Skills and Gross Motor Function

27 de julio de 2026 actualizado por: Riphah International University

Effects of Reflex Mediated Core Stability Exercise on Sensory Processing Skills and Gross Motor Function in Children With Cerebral Palsy

Current literature on DNS in CP primarily focuses on motor outcomes like postural control and balance. Therefore, there are fewer studies up to researcher's knowledge about DNS's impact on broad sensory processing skills in CP. The study will investigate the direct effect of reflex-mediated core stability exercises on a comprehensive range of sensory processing skills in children with CP.

Descripción general del estudio

Descripción detallada

Reflex-mediated core stabilization, also known as dynamic neuromuscular stabilization (DNS). Dynamic Neuromuscular Stabilization (DNS) is a rehabilitation approach based on developmental kinesiology, which observes infant motor behavior from birth to walking. Proposed by Pavel Kolar, it emphasizes posture, breathing patterns, and joint centration, focusing on core stability provided by muscles such as the diaphragm, transverse abdominis, and multifidus. DNS aims to improve muscle strength and endurance by enhancing neuromuscular coordination and integrating the spinal stabilization system. Cerebral Palsy (CP) is a neurodevelopmental disorder affecting posture and mobility due to non-progressive brain lesions, often presenting with abnormal muscle tone, weakness, poor trunk control, and sensory, perceptual, communication, and cognitive issues. Sensory-processing disorders are frequently observed in children with CP. While traditional core stability exercises and sensory integration therapies have shown benefits, this study aims to specifically investigate the comprehensive impact of reflex-mediated core stability exercises (DNS) on both sensory processing skills and overall gross motor function in children with CP.

The study design will be Randomized Controlled Trial, conducted over 10 months at Sehat Medical Complex in Lahore. A total of 26 participants, with 13 in each group, will be recruited using non-probability convenient sampling. Inclusion criteria include children aged 4-12 years diagnosed with spastic-type CP (diplegic) classified within GMFCS Levels III-V who can follow simple verbal instructions, and whose legal guardian provides informed consent. Exclusion criteria encompass severe cognitive impairment, severe muscle contracture >10 degrees or bone deformity, and significant communication deficits. Data will be collected using the Sensory Profiling (SP) and Gross Motor Function Measure-88 (GMFM-88) tools. The experimental Group A will receive 30 minutes of reflex-mediated core stabilization exercises five times weekly, followed by 20 minutes of conventional therapy for 8 weeks. Group B, the control group, will receive conventional therapy. The synopsis will be presented to the Research Ethical Committee of Riphah International University, Lahore, for ethical approval to conduct this study. Data will be analyzed through SPSS version 27.0

Tipo de estudio

Intervencionista

Inscripción (Actual)

26

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Lahore, Pakistán
        • Sehat Medical Complex Hanjarwal

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Children with both genders.
  • Children diagnosed with Cerebral Palsy (CP).
  • Children aged between 4-12 years (12).
  • Children with spastic-type Cerebral Palsy (diplegic) classified within Gross Motor Function Classification System (GMFCS) Levels III-V.
  • Ability to understand and consistently follow simple verbal instructions.
  • Informed written consent obtained from the child's legal parent or guardian.

Exclusion Criteria:

  • Children with severe cognitive impairment.
  • Severe muscle contracture >10 degrees or bone deformity significantly limiting participation in exercises.
  • Children with significant Communication Deficits
  • Any operational procedure within the last six months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Reflex mediated core stability exercise

the exercises are progressed over the six weeks and include positions such as:

  • Supine Lying
  • Prone Position
  • Side Lying Position
  • Quadripod Positio
  • Tripod Position
  • Squat

The exercises are progressed over the six weeks and include positions such as:

  • Supine Lying
  • Prone Position
  • Side Lying Position
  • Quadripod Position
  • Tripod Position
  • Squat

Participants will be given 20 min of conventional therapy for 8 weeks, five times weekly.

Therapy includes:

Facilitatory techniques are used for gross motor control such as:

  • Quadruped activities
  • Crawling
  • Kneeling
  • Sitting
  • Walking

It also incorporates exercises like:

  • Passive stretches for adductors, hamstrings, quadriceps, and calf muscles in both limbs (three repetitions with a 10-second hold).
  • Active and passive range-of-motion exercises for the lower limbs in sitting and supine positions (three sets with 10 repetitions).
Experimental: conventional therapy

Participants will be given 20 min of conventional therapy for 8 weeks, five times weekly.

Therapy includes:

Facilitatory techniques are used for gross motor control such as:

  • Quadruped activities
  • Crawling
  • Kneeling
  • Sitting
  • Walking

It also incorporates exercises like:

  • Passive stretches for adductors, hamstrings, quadriceps, and calf muscles in both limbs (three repetitions with a 10-second hold).
  • Active and passive range-of-motion exercises for the lower limbs in sitting and supine positions (three sets with 10 repetitions).

Participants will be given 20 min of conventional therapy for 8 weeks, five times weekly.

Therapy includes:

Facilitatory techniques are used for gross motor control such as:

  • Quadruped activities
  • Crawling
  • Kneeling
  • Sitting
  • Walking

It also incorporates exercises like:

  • Passive stretches for adductors, hamstrings, quadriceps, and calf muscles in both limbs (three repetitions with a 10-second hold).
  • Active and passive range-of-motion exercises for the lower limbs in sitting and supine positions (three sets with 10 repetitions).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sensory processing skills
Periodo de tiempo: baseline and after 6 weeks
Sensory profiling was designed by an occupational therapist. The questionnaire assessing the sensory processing of children aged 3-10 was filled out by their parents or caregivers. It consisted of 125 items. The survey consisted of 14 subsections under 3 main headings. These main topics were sensory processing, modulation, and emotional behavioral responses.
baseline and after 6 weeks
Gross motor function
Periodo de tiempo: baseline and after 6 weeks
The Gross Motor Function Measure (GMFM) is a tool that has been developed to assess change in gross motor function in children with cerebral palsy aged 5 months to 16 years of age.
baseline and after 6 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Saifah Ashfaq, dpt, ripah international university

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de abril de 2026

Finalización primaria (Actual)

20 de julio de 2026

Finalización del estudio (Actual)

27 de julio de 2026

Fechas de registro del estudio

Enviado por primera vez

5 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de julio de 2026

Publicado por primera vez (Actual)

28 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

27 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • REC/RCR&AHS/25/0705

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir